Exploratory Outcomes
postbiopsy, postbiopsy infection
ADVERSE EVENTS
Hospitalization rates within 30 days after biopsy amounted 2.6% (n = 17) (CG) and 1.3% (n = 8) (IG) (reduction, −1.3%; 95% CI: −.003 to .031). Patients were hospitalized for a median of 4 days (IQR, 3–5), mostly within the first week after biopsy (92.0%). No patients were admitted to the intensive care unit. One patient died during the follow-up period (unrelated to postbiopsy infection). Within 7 days postbiopsy, a total of 62 antibiotics were prescribed (441 treatment days) in the CG compared with 30 antibiotics (233 treatment days) in the IG. Within 30 days after biopsy, a total of 74 antibiotics (552 treatment days) were prescribed in the CG compared with 45 antibiotics (371 treatment days) in the IG. In both groups, the median number of antibiotics and total treatment duration per patient were comparable, namely 2 antibiotics for 14 days. No remarkable differences in adverse events between the different prophylactic agents were observed.